NSE - Delayed Quote
INR
Aurobindo Pharma Limited (AUROPHARMA.NS)
1,681.40
+21.50
(+1.30%)
At close: October 30 at 3:28:19 PM GMT+5:30
Loading chart for AUROPHARMA.NS
- Previous Close
1,659.90 - Open
1,652.00 - Bid --
- Ask --
- Day's Range
1,647.20 - 1,687.00 - 52 Week Range
1,106.00 - 1,740.00 - Volume
952,194 - Avg. Volume
891,788 - Market Cap (intraday)
967.44B - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
26.27 - EPS (TTM)
64.00 - Earnings Date Nov 4, 2026
- Forward Dividend & Yield 4.00 (0.00%)
- Ex-Dividend Date Aug 8, 2025
- 1y Target Est
1,757.15
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
AUROPHARMA.NS
42.13%
S&P BSE SENSEX (^BSESN)
12.63%
1-Year Return
AUROPHARMA.NS
52.51%
S&P BSE SENSEX (^BSESN)
11.78%
3-Year Return
AUROPHARMA.NS
96.81%
S&P BSE SENSEX (^BSESN)
16.14%
5-Year Return
AUROPHARMA.NS
150.69%
S&P BSE SENSEX (^BSESN)
25.55%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
10.63%
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
349.35B
-
Net Income Avi to Common (ttm)
37.13B
-
Diluted EPS (ttm)
64.00
Balance Sheet and Cash Flow
-
Total Cash (mrq)
105.85B
-
Total Debt/Equity (mrq)
21.31%
-
Levered Free Cash Flow (ttm)
--
